Simotinib as a modulator of P-glycoprotein: substrate, inhibitor, or inducer?

Anti-cancer Drugs
Lingling HuangQubo Zhu

Abstract

As a new antitumor drug, simotinib hydrochloride is prescribed for prolonged periods, often to patients with comorbidities. Therefore, the risk for developing drug resistance and drug-drug interactions between simotinib and other agents has to be taken into consideration. As P-glycoprotein (P-gp) is an efflux transporter, which plays a significant role in drug resistance and influences the pharmacological properties and toxicities of the drugs it interacts with, the interactions between simotinib and P-gp were investigated. Cytotoxicity was measured using the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide assay. Intracellular drug concentrations were detected by high-performance liquid chromatography, fluorescence-activated cell sorting and using a fluorescence reader. P-gp ATPase activity was measured using the Pgp-Glo assay, and intracellular pH was assessed using the fluorescent probe 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl. The expression and transcription of P-gp were detected by western blotting and the luciferase assay. Simotinib has no cross-resistance to P-gp substrates, and its efflux rate was independent of either the P-gp expression or the coadministered P-gp substrate. Simo...Continue Reading

References

Aug 10, 2000·Biochemical Pharmacology·C H YangY C Chen
Jan 31, 2002·Annual Review of Medicine·Michael M Gottesman
Mar 21, 2002·Nature Reviews. Cancer·Michael M GottesmanSusan E Bates
Mar 18, 2004·International Journal of Cancer. Journal International Du Cancer·Laurent CandeilMaguy Del Rio
Apr 23, 2005·Toxicology and Applied Pharmacology·Elaine M LeslieSusan P C Cole
Jun 16, 2005·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Takeshi KitazakiShigeru Kohno
Aug 23, 2005·Endocrine-related Cancer·Roberto BiancoFortunato Ciardiello
Mar 7, 2006·Nature Reviews. Drug Discovery·Gergely SzakácsMichael M Gottesman
May 3, 2006·Cancer Research·Markos LeggasClinton F Stewart
Jun 8, 2006·Annual Review of Biochemistry·Alexander Levitzki, Eyal Mishani
Sep 26, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Cheng ChangSean Ekins
Oct 15, 2008·Biochemical and Biophysical Research Communications·Ying LuShigeo Wakabayashi
Oct 27, 2009·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Sandra RocheRobert O'Connor
Jul 8, 2010·Investigational New Drugs·Gráinne DunneRobert O'Connor
Sep 4, 2010·Current Drug Metabolism·Xiao-Kun Wang, Li-Wu Fu
Feb 14, 2012·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Suneet ShuklaSuresh V Ambudkar
Apr 10, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·C JoveletS Gil
May 19, 2012·Bioorganic & Medicinal Chemistry·Vasanthanathan PoongavanamGerhard F Ecker
Jan 2, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·S HarmsenJ H M Schellens
Jun 19, 2013·Journal of Medicinal Chemistry·Jurica LevatićFran Supek
Jan 9, 2014·Clinical Drug Investigation·Sven WindPeter Stopfer
Jan 15, 2015·Anti-cancer Agents in Medicinal Chemistry·Subburayan Karthikeyan, Sugeerappa Laxmanappa Hoti

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
Assay
electrophoresis
ELISA

Software Mentioned

SPSS
ModFit LT

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis